86.90
-0.80%
Close of 9 Nov 2026, in DKK
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Ambu A/S
Its shares trade on Nasdaq Copenhagen under the ticker AMBU B.CO. It has been listed since 9 March 1992. In the fiscal year to 30 September 2025, it reported revenue of DKK 6.04bn and net income of DKK 609.0m. At that date it held total assets of DKK 7.67bn and shareholders' equity of DKK 6.04bn.
Ambu A/S engages in the development, production, and marketing of diagnostic and life-supporting devices for hospitals and rescue services. The Company’s operations are structured into three business areas: Anaesthesia, Patient Monitoring & Diagnostics and Emergency Care. The Anaesthesia business area offers a range of products from resuscitators, face masks and laryngeal masks to the single use flexible intubation scope. The Patient Monitoring & Diagnostics business area comprises single use electrodes for cardiological and neurological examinations. The target groups for these products are hospitals, clinics, ambulance services and sleep labs. The Emergency Care business area offers ventilation bags, neck collars and manikins for first-aid training. The firm markets its products worldwide. The firm operates King Systems Inc, First Water Heathcote Ltd and Invendo Medical GmbH as subsidiaries.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 9 Mar 1992
- Employees
- 3,278
- Website
- ambu.com/corp/home.aspx ↗
Leadership
Pay as last reported
- Mr. Joergen JensenIndependent Chairman of the BoardDKK 1.5m
- Ms. Britt Meelby JensenChief Executive Officer, Member of the Executive Board, since 2019DKK 22.9m
- Ms. Shacey PetrovicIndependent Vice Chairman of the Board, since 2022DKK 999,000
- Mr. Henrik BenderChief Financial Officer, Member of the Executive BoardDKK 8.0m
- Mr. Steven BlockPresident of Ambu USA
- Ms. Graziela MalucelliChief Operations Officer
- Ms. Sanne HjordrupChief People & Culture Officer
- Mr. Finn MohringChief Technology Officer, R&D, since 2023
- Mr. Bassel RifaiPresident of EMEA & APAC Sales, Chief Marketing Officer
- Mr. Jesper Mads Bartroff FrederiksenDirector, Employee RepresentativeDKK 350,000
- Ms. Charlotte BjoernhofDirector, Employee RepresentativeDKK 350,000
- Mr. David HaleDirector
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 68
- Environment
- 68
- Social
- 64
- Governance
- 73
- Direct emissions (scope 1)
- 3,369 t
- Energy emissions (scope 2)
- 23,173 t
- Value chain emissions (scope 3)
- 190,388 t
- Women in the workforce
- 63%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Ambu A/S has several strengths that contribute to its competitive advantage:
- Despite its strengths, Ambu A/S also faces certain weaknesses that need consideration:
- Ambu A/S can leverage the following opportunities to drive growth:
- Ambu A/S should be aware of the following threats that could impact its business:
Weaknesses
- Despite its strengths, Ambu A/S also faces certain weaknesses that need consideration:
- Ambu A/S can leverage the following opportunities to drive growth:
- Ambu A/S should be aware of the following threats that could impact its business:
Opportunities
- Ambu A/S can leverage the following opportunities to drive growth:
- Ambu A/S should be aware of the following threats that could impact its business:
Threats
- Ambu A/S should be aware of the following threats that could impact its business:
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.